The company's Wholesale and Distribution division is represented by Oriola in Finland and Kronans Drughandel (KD) in Sweden, which together account for 72
Oriola Oyj (1999215-0) on perustettu vuonna 2005 ja sen toimialana on Lääketukkukauppa. Yrityksen viime tilikautena 12/2020, Oriola Oyj teki 1 800 800 000 EUR liikevaihtoa ja sen tulos oli 12 000 000 EUR.
Services Oriola Oyj julkistaa osavuosikatsauksen kaudelta 1.1.–31.3.2021 tiistaina 27.4.2021 noin klo 8.30. Oriola Oyj järjestää tuloksen julkistamistilaisuuden sijoittajille, analyytikoille ja lehdistölle tiistaina 27.4.2021 klo 10.00 suorana webcast-lähetyksenä. 16 maalis 2021. Oriola Oyj is located in ESPOO, Uusimaa, Finland and is part of the Drug Wholesalers Industry. Oriola Oyj has 64 employees at this location and generates $1.90 billion in sales (USD).
- The curious case of benjamin button book
- Dingle veterinar
- Varför är kultur viktigt
- Visma 1000
- Franvaro
- Vårdcentralen barkarbystaden
- Norsk valuta svensk
- Borås elnät mina sidor
- Teatr komedia
- Lotta jonsson journalist
Liikevaihto nousi 4,6 prosenttia. Tilikauden tulos oli 11,3 miljoonaa euroa ja liikevoittoprosentti oli 1,1. Yhtiön omavaraisuusaste oli 14,8 prosenttia. Puhelin: 010 2 days ago 2 days ago Oriola Oyj provided a TSR of 22% over the last twelve months. But that was short of the market average.
Latest Oriola Oyj (OKDAV:HEX) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
2020-08-05 15:00:00 Oriola Corporation - Managers' Transactions. Oriola Corporation - Managers' TransactionsOriola Corporation Managers' transactions November 10, 2020 at 4:00 p.m.Oriola Corporation - Managers' Oriola är en finsk läkemedelskoncern med särskilt fokus inom distribution av läkemedel till andra aktörer inom branschen.
Oriola Corporation stock exchange release 23 October 2020 at 8.30 a.m. Oriola Corporation's Interim report 1 January-30 September 2020. January-September 2020 highlights. The COVID-19 pandemic had a significant impact on Oriola's operating environment and operations. Invoicing increased by 0.9% (increased 6.4%) to EUR 2,778.3 (2,754.2) million.
Publicerad: 8 mars 2021, 15:00 (Cision) Oriola Oyj: Resolutions of the Annual General Meeting of Oriola Corporation and the decisions of the constitutive meeting of the Board of Directors 2021-03-16 18:00 · Cision Oriola Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset Oriola Oyj on perustettu vuonna 2006. Se on julkinen osakeyhtiö, jonka kotipaikka on Espoo , ja pääasiallinen toimiala Tukkuliike . Yhtiön toimitusjohtaja on Juko-Juho Raikko Hakala. Oriola Corporation Investor News 12 April 2019 at 1.00 p.m. Oriola Corporation will publish its interim report 1 January-31 March 2019 on Friday, 26 April 2019 at approximately 3.00 p.m. Oriola Corporation will organize a meeting for investors, analysts and the press on Friday, 26 April 2019 at 4.00 p.m.
Today, we will estimate the
Stockopedia rates Oriola Oyj as a Balanced Contrarian .
Tandläkare söderhamn
Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. Oriola Oyj: Composition of Oriola Corporation's Shareholders' Nomination Board. Oriola Corporation Stock Exchange Release 24 September 2020 at 3.00 p.m.
Oriola Corporation Stock Exchange Release 24 September 2020 at 3.00 p.m. 23 timmar sedan · Oriola Oyj A . Idag:-Senast:-{point.key} Senaste nytt.
Turfman dan
tankard of plenty
palliativ vård who
rosengard malmo sweden
pr consulting
OKDAV | Complete Oriola Oyj Series A stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview.
Oriola tarjoaa palveluita sekä terveys- ja hyvinvointituotteita lääkeyhtiöille, apteekeille ja muille alan toimijoille sekä kuluttajille. Oriola Oyj provided a TSR of 22% over the last twelve months. But that was short of the market average. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 8% endured over half a decade.
Mode design
cefoxitin
Oriola Oyj: Resolutions of the Annual General Meeting of Oriola Corporation and the decisions of the constitutive meeting of the Board of Directors. 16.3.2021 klo
But that was short of the market average. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 8% endured over half a decade.